Helicobacter project (AstraZeneca)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHelicobacter project (AstraZeneca)
Drug Alias NameHelicobacter pylori project (AstraZeneca)antimicrobials (Astra)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstraAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A
Related LinksN/A